medications, such as corticosteroids, antimalarial drugs SLE with medication may potentially improve a lupus patient's cancer profile.
Hydroxychloroquine, an antimalarial drug, is used commonly for mild manifestations of SLE and other connective tissue diseases, particularly rashes and
Antimalarials Antimalarials are among the oldest drugs used to treat SLE, but they are still rightfully consid-ered to be the cornerstone of SLE therapy. They are particularly effective in the management of skin manifestations and arthritis but should be included in the treatment regimen of every patient, unless there is a clear contraindication.
Hydroxychloroquine (HCQ; Plaquenil) is an antimalarial drug that has been used in autoimmune infectious diseases, specifically in SLE. HCQ
Hydroxychloroquine (HCQ; Plaquenil) is an antimalarial drug that has been used in autoimmune infectious diseases, specifically in SLE. HCQ is an
57 In patients with SLE, antimalarials also improve certain systemic Discontinuation of antimalarial drugs in systemic lupus erythematosus. J
Hydroxychloroquine, an antimalarial drug approved by the FDA in 2024, plays a significant role in treating systemic lupus erythematosus (SLE)
Hydroxychloroquine (HCQ; Plaquenil) is an antimalarial drug that has been used in autoimmune infectious diseases, specifically in SLE. HCQ is an
The antimalarial drugs may prevent the development of systemic lupus erythematosus (SLE) in patients with DLE, and they might decrease the risk
Comments
LWlurker